Return on Equity (ROE)
Updated 8h ago
Sector Performance
60th percentileVZ
17.2%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
Return on Equity (ROE) measures how much profit a company generates for every dollar of shareholders' equity — a 17.2% ROE means Verizon earns $0.172 for each dollar of equity invested.
This figure sits above the sector median of 13.8%, placing Verizon in the 60th percentile among its sector peers, indicating above-average profitability efficiency. No year-over-year or quarter-over-quarter changes are available, and the trend direction over the last eight quarters is also not provided, leaving the metric's trajectory unknown. The combination of a high current ROE with no trend data creates an unclear picture: the strong level suggests efficient equity use, but the absence of historical movement makes it impossible to assess stability or direction. This supports the overall NEUTRAL verdict, as the metric offers a positive snapshot without the trend context needed for a more definitive stance.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about VZ?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are VZ's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master VZ's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full VZ research report →VZ
17.2%
Sector Median
13.8%
Sector Avg
31.4%
How VZ's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.